| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |